Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Coordination and Support Action · Running

MPS_NOVA MPS NOVA Hub: Advanced Microphysiological Systems and Pluripotent Stem Cell Technologies to Unveil Chronic Disease Mechanisms and Host-Microbe Interactions

Coordinator
Universidade Nova De Lisboa, Portugal
Runs
1 October 2024 to 30 September 2027
Status
Running
EU funding
€1.5m
Total cost
—
Partners
4 organisations in 3 countries
Type
Coordination and Support Action
Grant agreement
101159729

What the project is doing

In the project's own words, from its summary on CORDIS.

Mitigating the current rise in chronic diseases and effectively addressing the enduring challenges posed by infectious diseases are pressing concerns in 21st-century healthcare. These challenges demand innovative research approaches, and microphysiological systems (MPS) have emerged as promising tools for the study of these conditions, as they are capable of replicating near-native human physiology, with significant potential for precision medicine.

However, the adoption of MPS technology in Portugal lags behind, primarily due to the high expertise required. To bridge this gap, we will establish a European collaborative network, MPS_NOVA, under the coordination of the University Nova of Lisbon (UNL). This will bring together leading European institutions specializing in MPS and stem cell research, including UKJ (Germany), MDC-BIMSB (Germany), and FHT (Italy). These will collectively offer a broad range of expertise and approaches in the field of MPS and stem cell methodologies, which will fortify UNL's existing multidisciplinary knowledge and expertise, foster best practices in research and training, and expand collaborative networks.

By doing so, it will enhance the capabilities, excellence, visibility, and reputation of UNL's research, researchers, and research management staff. For this, a variety of network and research activities have been devised, focusing on the integration of these cutting-edge technologies at UNL, by facilitating collaborative projects and promoting knowledge exchange among partners. Key to these achievements is the upskilling of ITQB NOVA and NMS research managers, who will benefit from tailored partner training in HR excellence, effective management strategies and optimized communication.

Together, MPS_NOVA will create a European Center of Excellence in MPS and stem cell research in Portugal, driving breakthrough advances in chronic diseases and host-microbe interactions, benefiting basic and applied research, and society at large.

Topics

Who is involved

OrganisationCityCountryRole
Universidade Nova De LisboaLisboaPortugalCoordinator
Max Delbrueck Centrum Fuer Molekulare Medizin in Der Helmholtz-Gemeinschaft (mdc)BerlinGermanyParticipant
Universitatsklinikum JenaJenaGermanyParticipant
Fondazione Human TechnopoleMilanoItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI